Basic Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Nov 28, 2019; 25(44): 6508-6526
Published online Nov 28, 2019. doi: 10.3748/wjg.v25.i44.6508
Table 2 NALT1 expressions and clinicopathologic parameters
CharacteristicsNALT1
LowHighP valueχ2
159 (47.3)177 (52.7)
Age0.4440.680
≥ 6088 (49.4)90 (50.6)
< 6071 (44.9)87 (55.1)
Gender0.5510.410
Male109 (46.2)127 (53.8)
Female50 (50.0)50 (50.0)
Tumor size0.6590.236
≥ 5 cm65 (45.8)77 (54.2)
< 5 cm94 (48.5)100 (51.5)
Location0.5891.058
Up32 (42.7)43 (57.3)
Middle42 (46.7)48 (53.3)
Low85 (49.7)86 (50.3)
Bormann type0.2084.549
I13 (52.0)12 (48.0)
II77(52.4)70 (47.6)
III68 (42.8)91 (57.2)
V1 (20.0)4 (80.0)
Tumor histological morphology0.5691.126
Adenocarcinoma123 (47.3)137 (52.7)
Absolute signet ring cell carcinoma35 (46.7)40 (53.3)
Mixed carcinoma1 (100)0 (0)
Lauren type0.1903.326
Intestinal71 (45.5)85 (54.5)
Mixed carcinoma31 (41.3)44 (58.7)
Diffuse57 (54.3)48 (45.7)
Tumor differentiation0.000247.392
Moderate and high151 (90.4)16 (9.6)
Poor8 (4.7)161 (95.3)
Vessel invasion0.4710.658
Yes43 (43.9)55 (56.1)
No116 (48.7)122 (51.3)
Perineural invasion0.7060.195
Yes38 (45.2)46 (54.8)
No121 (48.0)131 (52.0)
T category0.0358.619
T137 (61.7)23 (38.3)
T210 (45.5)12 (54.5)
T38 (66.7)4 (33.3)
T4104 (43.0)138 (57.0)
N category0.00020.693
N086 (61.9)53 (38.1)
N122 (37.9)36 (62.1)
N226 (40.0)39 (60.0)
N325 (33.8)49 (66.2)
TNM stage0.00117.625
I41 (59.4)28 (40.6)
II49 (60.5)32 (39.5)
III68 (37.0)116 (63.0)
IV1 (50.0)1 (50.0)